Schwab Gisela
SEC CIK 1213140 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | Pres, CMO, Prod Dev, Med Aff | 689.1K | — | — | 2 | 2021-07-21 | 2021-07-26 |
Most active insiders at EXEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aftab Dana | EVP, Research, Development | — | $7.70M |
| 2 | Haley Patrick J. | EVP, Commercial | — | $7.60M |
| 3 | Smith Julie | Dir | — | $4.69M |
| 4 | WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| 5 | Senner Christopher J. | EVP, CFO | — | $4.56M |
| 6 | PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| 7 | POSTE GEORGE | Dir | — | $2.74M |
| 8 | Beckerle Mary C | Dir | — | $1.93M |
| 9 | Oliver Bob | Dir | — | $1.33M |
| 10 | Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Schwab Gisela made no open-market trades at EXEL in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-28 | 2021-07-26 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, CMO, Prod Dev, Med Aff | M - OptEx | $4.20 | +40.0K | 689.1K | +6% | +$168.0K |
| D | 2021-07-23 | 2021-07-21 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, CMO, Prod Dev, Med Aff | M - OptEx | $4.20 | +35.0K | 649.1K | +6% | +$147.0K |
Purchase Sale Sale after option exercise All abbreviations